Smith & Nephew PLC
LSE:SN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Smith & Nephew PLC
LSE:SN
|
UK |
|
X
|
Xilio Therapeutics Inc
NASDAQ:XLO
|
US |
Wall St Price Targets
SN Price Targets Summary
Smith & Nephew PLC
According to Wall Street analysts, the average 1-year price target for SN is 1 453.76 GBX with a low forecast of 1 262.5 GBX and a high forecast of 1 785 GBX.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SN's stock price target?
Price Target
1 453.76
GBX
According to Wall Street analysts, the average 1-year price target for SN is 1 453.76 GBX with a low forecast of 1 262.5 GBX and a high forecast of 1 785 GBX.
What is the Revenue forecast for Smith & Nephew PLC?
Projected CAGR
7%
Over the last 14 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 5 years is 7%.
What is the Operating Income forecast for Smith & Nephew PLC?
Projected CAGR
12%
Over the last 14 years, the compound annual growth rate for Operating Income has been 2%. The projected CAGR for the next 5 years is 12%.
What is the Net Income forecast for Smith & Nephew PLC?
Projected CAGR
2%
Over the last 14 years, the compound annual growth rate for Net Income has been 1%. The projected CAGR for the next 5 years is 2%.
